Biotech Showcase™ is an investor and networking conference devoted to providing private and
small- and mid-cap biotechnology companies an opportunity to present to and meet with
investors and biopharmaceutical executives during the course of one of the largest annual
healthcare conferences that attracts investors and biopharmaceutical executives from
around the world.
The 2018 event showed a substantial increase in the number of presenting companies, as
well as significant growth in the number of attendees and one-to-one meetings. Now in its
eleventh year, Biotech Showcase 2019 is expected to feature presentations by over 400
public and private companies and attract more than 3,600 attendees, including 900
investors. The event will run a full program of topical plenary sessions and workshops,
including special-focus events dedicated to emerging trends.
The demand for innovation in all areas of human health is the impetus behind Digital
Medicine & Medtech Showcase, a focus event taking place during Biotech Showcase at
Parc 55 in San Francisco. The event brings together key stakeholders at the convergence of
traditional therapeutics, digital tools, combination products, companion diagnostics,
precision medicine, AI and other technical advances to explore funding opportunities,
partnerships and collaboration.
Biotech Showcase is co-produced by Demy-Colton Life Science Advisors and EBD Group.
Both organizations have a long history of providing high quality business support services to
the biotechnology industry.
Intended for:
Executives from:
● Established and emerging public and private biotech companies
● Professional investors in public and private biotech and life science companies
● Pharmaceutical companies
● Professional advisors to the biotechnology and life sciences community
